Performance

DNTH +148.07%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
DNTH	+4.61%	+118.39%	+148.07%	—	-37.83%	1.74	0.00%

Summary

DNTH at a glance

DNTH returned +148.07% over the past year. Its worst drop in that year was -37.83%, smaller than 41% of stocks on Redstone, and its Sharpe ratio of 1.74 beats 96% of stocks on Redstone. It pays no dividends.

Ranking

How DNTH ranks

Current Drawdown

-22.39%

Rolling Volatility

46.11%

Actions

Metrics

Risk Indicators

Alpha95.41%

Beta1.02x

Sharpe1.74

Sortino3.11

Omega1.37

Calmar3.91

Martin8.33

Profile

About DNTH

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases.

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $5.0B
Listed: Sep 2023
Employees: 92
Headquarters: New York, NY
Website: dianthustx.com

Comparisons

DNTH: Dianthus Therapeutics, Inc.

DNTH at a glance

How DNTH ranks

Current Drawdown

Rolling Volatility

About DNTH

Related comparisons